The aim of this study is to identify through a whole exome sequencing approach, the underlying familial predisposition to breast cancer in multiple multi-generational breast cancer families in whom no BRCA1 or BRCA2 mutation was identified (BRCA1/2 negative families), and to assess the candidate genes identified by this means in a cohort of familial BRCA1/2 negative breast and ovarian cancer patients. The gene discussed is BRCA1; the disease is ovarian carcinoma.